EU GMP Certification sends this small-cap pharma stock flying over 14%: Medicamen Biotech share price

EU GMP Certification sends this small-cap pharma stock flying over 14%: Medicamen Biotech share price



Medicamen Biotech shares zoom: Shares of pharmaceutical company, Medicamen Biotech, climbed as much as 14.29 per cent to Rs 507 on the BSE during intra-day deals on Thursday. The uptick in the stock price followed the news that the company’s General Tablets and Liquid Orals Formulation facility, located in Bhiwadi, received the EU GMP certification from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, Greece.


“We wish to inform you that the company’s General Tablets and Liquid Orals Formulation facility located at SP 1192 A & B, Phase IV, Industrial Area, Bhiwadi – 301019, received the final approval (EU GMP Certification) today, from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, Greece,” said Medicamen Biotech in a regulatory filing on the BSE.

 


Medicamen Group, established in December 1993, has vertically integrated facilities for R&D, APIs, and Formulations. As per the information available on their website, the pharmaceutical company is now focusing on oncology therapeutics and other generics with a vision to be a global leader in oncology generics by offering affordable medicine with best-in-class quality. Apart from the above, a set of 10 non-oncology formulations is also being developed in R&D for EU market filings. 


Medicamen Biotech has a market capitalisation of Rs 617.74 crore on the BSE, as of September 12, 2024. The pharmaceutical company is a constituent of the BSE smallcap index.


The small-cap pharma stock has advanced 16.15 per cent in the last one week, and 20 per cent in the last one month. Shares have yielded a return of 20.02 per cent in the last six months, while they dropped 28.39 per cent in the last one year, as per the data available on the BSE.


The pharmaceutical company’s shares continue to trade northward on the bourses today. At around 01:33 PM, shares of Medicamen Biotech were quoted trading at Rs 485.85, up 9.52 per cent from their previous close of Rs 443.60 on the BSE. Nearly 0.37 lakh equity shares of the smallcap pharma company worth nearly Rs 1.85 crore have exchanged hands on the BSE.


Medicamen Biotech shares are currently trading at a discount of 36 per cent from their 52-week high of Rs 765, which they touched on September 28, 2023, on the BSE.

First Published: Sep 12 2024 | 1:53 PM IST



Source link

Vedanta climbs 2% on demerger timeline update, first dollar-bond issue

Vedanta climbs 2% on demerger timeline update, first dollar-bond issue


Vedanta shares gained 2.5 per cent on the BSE on Thursday, September 12. The counter saw buying around two major news items that were regarding the conglomerate’s demerger and its parent raising $900 mn via its first dollar bond issue to repay past loans.


At around 12:24 PM, shares of Vedanta were up 1.15 per cent at Rs 430.8 per share on the BSE. In comparison, the BSE Sensex was up 119.96 points at 81,643.12.


On Wednesday, John Slaven, CEO of the aluminium business of Vedanta, said, Vedanta’s demerger of mining conglomerate is expected by the end of FY25.

 


Vedanta has filed an application for its demerger scheme before the National Company Law Tribunal (NCLT). The company has already received approval from 75 per cent of its secured creditors for the proposed demerger of its businesses.


“It’s not within our control. It’s the NCLT process. They typically take, I don’t know, four to six months, to run that process. So by the end of this fiscal year, by the end of this fiscal year (I see it happening),” said Slaven. 

The proposed demerger will create independent companies housing aluminium, oil and gas, power, steel and ferrous materials, and base metals businesses. The existing zinc and new incubated businesses will remain under Vedanta Ltd. READ MORE


In another development, London-listed Vedanta Resources, the parent firm of mining conglomerate Vedanta, on Wednesday raised $900 million in its first dollar-denominated bond issue in more than two years to prepay existing debt.


In a statement, the company said it has raised $900 million at a coupon rate of 10.875 per cent in the five-year US dollar-denominated bond.

“The net proceeds from the offering of the bonds will be used to repay certain of Vedanta’s existing bonds (including any accrued interest thereto) and to pay any related transaction costs in connection thereto,” it said. READ MORE


In the past one year, the shares of Vedanta have gained 83.73 per cent, compared to the BSE Sensex’s rise of 21.2 per cent during the same period. 

First Published: Sep 12 2024 | 12:35 PM IST



Source link

Sebi considers new stricter rules to curb risks as tiny IPOs boom

Sebi considers new stricter rules to curb risks as tiny IPOs boom


In July, the NSE set a 90 per cent cap on listing gains, while the regulator itself has consistently urged investors to be cautious when investing in SME firms | (Photo: Shutterstock)


By Chiranjivi Chakraborty

 


India’s securities regulator is considering tighter oversight on micro-cap firms going public, including monitoring the use of their funds and imposing stricter due diligence guidelines for merchant bankers, according to a person involved in the discussions.

 


Mandating a longer track record of profitability and greater scrutiny of financial statements are the other potential steps under review, the person said, asking not be identified as the details are private. This follows incidents of fraud in this segment of the market, they added.


Even so, the Securities and Exchange Board of India is not inclined to take over the listing approval process for small and medium enterprises from the National Stock Exchange of India Ltd. and BSE Ltd., the person said. Some investors have been asking for the regulator’s direct oversight in this process. The discussions are still at a preliminary stage and measures may be revised before an initial draft is presented to the regulator’s primary market advisory panel.

 

India’s market for micro-listings has boomed since the pandemic, driven by investor interest in tiny businesses that are seen as having the potential to expand amid accelerating economic growth. Just two weeks ago, a $1.4 million initial public offering by a motorcycle dealership with only two outlets and eight employees was oversubscribed more than 400 times, raising concerns about the quality of the offerings in this niche market.

Chart


The surge in investor appetite for shares of firms with an unproven track record as well as some instances of stock-price manipulation have sprung Indian authorities into action. In August, SEBI asked the BSE to halt the IPO of plywood maker Archit Nuwood Industries Ltd. due to concerns over its financial accounts, the person said. 


In July, the NSE set a 90 per cent cap on listing gains, while the regulator itself has consistently urged investors to be cautious when investing in SME firms. A discussion paper outlining stricter listing rules for this segment will be released by year-end, Ashwani Bhatia, a SEBI whole-time member, told reporters last month.


An email sent to the regulator and calls made to its spokesman seeking comment went unanswered.


“SEBI will be looking to strike the right balance between protecting investors and helping the market grow,” said Narinder Wadhwa, managing director at SKI Capital Services Ltd. “The regulator could consider additional criteria like increasing the lock-in period for anchor investors,” he said.

First Published: Sep 12 2024 | 11:42 AM IST



Source link

F&O Insights: Nifty pivot at 25,000; India VIX hints bullish bias building

F&O Insights: Nifty pivot at 25,000; India VIX hints bullish bias building


Illustration: Ajay Mohanty


F&O Insights for Thursday, September 12, 2024: The NSE Nifty 50 index has been gyrating around the 25,000 psychological mark and seeking support around its short-term moving average on the daily scale. 


Trading action in the derivatives segment was tepid yesterday even as Nifty tumbled over 1 per cent in intra-day deals. The volumes were on the lower side, with individual stock action taking centre-stage.


Jatin Gedia, Technical Research Analyst at Sharekhan by BNP Paribas in a note said, the Nifty has faced resistance in the 25,100 – 25,150 zone where the hourly upper Bollinger band and the 61.82 per cent Fibonacci retracement level is placed.

 


On the downside, support zone is placed at 24,800 – 24,750. The Bollinger bands are contracting suggesting rangebound price action over the next few trading sessions. The range of consolidation is likely to be 24,800 – 25,200, the analyst added.


With global cues turning favourable on Thursday, will the Nifty attempt an upside breakout? Here’s what the cues from the futures & options segment suggest:


Yesterday, the Nifty September futures dipped 0.6 per cent amid negligible rise in open interest (OI), suggesting lack of participation at lower levels. The premium in Nifty futures, however, declined to lowest point for the series to 20-odd points.


Whereas, the Bank Nifty futures shed 0.5 per cent alongside 5 per cent increase in OI, suggesting possible short additions. The premium in Bank Nifty futures, however, rose to 114 points from 99 points the day before.


Key Insights from Nifty, Bank Nifty options data:


In Nifty options, significant open interest is observed at the 24,500 Put (69.91 lakh contracts) and 25,000 Call (1.16 crore contracts), reflecting a bearish outlook as sellers hold strong positions at lower level, highlighted Dhupesh Dhameja, Technical Analyst at SAMCO 


Active trading was concentrated around the 24,900-24,950 Calls and 24,700-24,800 Puts. The Put-Call Ratio (PCR) dropped to 0.60 from 0.78, highlighting a cautious market environment with call writers in control. The Max Pain level remains at 25,000, a critical point for any potential trend reversal, the analyst added.


Dhupesh at the same time added that, in spite of a 2 per cent increase, India VIX remains below 15; this suggests that bullish momentum may be gaining strength as buyer interest grows.


In case of Bank Nifty, significant open interest is concentrated at the 51,100 Call (71.67 lakh contracts) and 51,000 Put (1.36 crore contracts), indicating a neutral outlook as traders adjust positions at higher levels.


Active trading was centred around the 51,100-51,200 Calls and 50,900-50,800 Puts. The Put-Call Ratio (PCR) has dipped slightly from 0.84 to 0.76, signalling a sideways to bearish sentiment, with call writers maintaining dominance at higher levels. The Max Pain point remains at 51,000, a key level for any potential market shift.


FII, DII trading activity in F&O – Here’s all you need to know about who bought and who sold in the derivatives market on September 11?


As per data from the NSE, FIIs net sold 6,286 contracts of index futures on Wednesday worth Rs 476.65 crore. FIIs net sold 5,778 contracts of Bank Nifty futures and 729 contracts of MidCap Nifty futures, while net bought 271 contracts of Nifty futures.


FIIs increased positions in Nifty futures by 1 per cent, while reducing the OI by 4 per cent in Bank Nifty futures yesterday. Pursuant to which, FIIs long-short ratio in index futures declined wee bit to 1.75:1 – this ratio implies that foreign investors hold around 5 long positions in index futures for every 3 bets on the short side. The FIIs longs in index futures stood at 63.58 per cent as of September 11.


At the same time, retail investors’ long-short ratio in index futures remained more or less unmoved at 0.89:1; implying a slight bias on the short side of trade.


Domestic institutional investors (DIIs) long-short ratio also was unmoved around 0.57:1; suggesting 3 long bets for every 5 short positions in index futures.


Bullish & Bearish stocks


Page Industries saw long buildup on Wednesday as the stock price gained 3.5 per cent on the back of 6.4 per cent increase in open interest. Bajaj Auto was the only other stock with notable buying activity in the derivatives segment yesterday.


On the other hand, Aarti Industries and Tata Motors saw aggressive short buildup with the stocks down 4.5 per cent and 6.3 per cent, respectively, on the back of 17.9 per cent and 12.8 per cent jump in OI. Birlasoft, Ashok Leyland and ONGC were the other key stocks with visible selling bias.


Stocks in F&O ban period today


Aarti Industries entered the F&O bank period, while Biocon moved out of the ban. Whereas, others such Aditya Birla Fashion & Retail, Balrampur Chini, Bandhan Bank, Chambal Fertilisers, Hindustan Copper and RBL Bank continued to remain in the F&O ban period; thus restricting creation of fresh positions in these counters.

First Published: Sep 12 2024 | 9:23 AM IST



Source link

YouTube
Instagram
WhatsApp